SHARE CONSOLIDATION EFFECTIVE & TOTAL VOTING RIGHT

Summary by AI BETAClose X

Reckitt Benckiser Group plc announces that its Share Consolidation is effective today, February 2, 2026, following shareholder approval for a Special Dividend. The company's issued share capital will now consist of 674,005,752 ordinary shares, with 29,252,346 held in treasury, resulting in a total of 644,753,406 voting rights. This figure will serve as the denominator for shareholders calculating their notification obligations under FCA rules.

Disclaimer*

Reckitt Benckiser Group PLC
02 February 2026
 

RECKITT BENCKISER GROUP PLC

SHARE CONSOLIDATION EFFECTIVE AND TOTAL VOTING RIGHTS

Further to the announcement on 27 January 2026 that shareholder approval was granted at the General Meeting for a Special Dividend and associated Share Consolidation, Reckitt Benckiser Group plc (the "Company") is pleased to announce that the Company's Share Consolidation becomes effective today.

Admission of the Company's new ordinary shares to the ESCC category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's Main Market for listed securities, is due to take place at 8.00 a.m. today.

The ISIN for the new ordinary shares is GB00BSZBP530.

As a result of the Share Consolidation and in accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company hereby notifies the market that the Company's issued share capital as at 8.00 a.m. on 2 February 2026 will consist of 674,005,752 ordinary shares of 10⁵⁄₁₂ pence each. The Company will hold 29,252,346 ordinary shares in treasury. Therefore, the total number of voting rights in the Company as at 2 February 2026 will be 644,753,406. 644,753,406 may be used by shareholders and others with notification obligations as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the Circular dated 7 January 2026.

For further Information:

Catheryn O'Rourke
Company Secretary
Tel. 01753 217 800

103-105 Bath Road, Slough SL1 3UH
Registered in England and Wales, No. 6270876

About Reckitt:

We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.

We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.

*Reckitt is the trading name of the Reckitt group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings